EDIT Trademark

Trademark Overview


On Monday, February 8, 2021, a trademark application was filed for EDIT with the United States Patent and Trademark Office. The USPTO has given the EDIT trademark a serial number of 90517570. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, November 4, 2022. This trademark is owned by Saliogen Therapeutics, Inc.. The EDIT trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Pharmaceutical preparations for genetically driven disorders, neurological, gastrointestinal, metabolic, immunological, dyslipidemias musculoskeletal, oncological disorders and diseases of the retina, liver, heart, lung, bone marrow, brain, muscle, immune system, and kidney; Reagents, nucleic acids, and nucleotides for medical and veterinary purposes

Reagents, nucleic acids, and nucleotides for scientific and research use in the fields of clinical research, drug development, agriculture and genetics research; reagent kits comprised of reagents and chemical preparations for scientific research purposes; samples of nucleotide sequence variants and modified nucleotide sequences for use in the fields of scientific research, clinical research, and scientific diagnostics research
edit

General Information


Serial Number90517570
Word MarkEDIT
Filing DateMonday, February 8, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, November 4, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for genetically driven disorders, neurological, gastrointestinal, metabolic, immunological, dyslipidemias musculoskeletal, oncological disorders and diseases of the retina, liver, heart, lung, bone marrow, brain, muscle, immune system, and kidney; Reagents, nucleic acids, and nucleotides for medical and veterinary purposes
Goods and ServicesReagents, nucleic acids, and nucleotides for scientific and research use in the fields of clinical research, drug development, agriculture and genetics research; reagent kits comprised of reagents and chemical preparations for scientific research purposes; samples of nucleotide sequence variants and modified nucleotide sequences for use in the fields of scientific research, clinical research, and scientific diagnostics research

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, May 12, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 12, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSaliogen Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Friday, November 4, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, November 4, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, November 4, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, November 3, 2022ASSIGNED TO EXAMINER
Thursday, May 26, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 26, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 26, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 19, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, April 19, 2022FINAL REFUSAL E-MAILED
Tuesday, April 19, 2022FINAL REFUSAL WRITTEN
Tuesday, March 8, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 7, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 7, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 7, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 7, 2021NON-FINAL ACTION E-MAILED
Tuesday, September 7, 2021NON-FINAL ACTION WRITTEN
Wednesday, September 1, 2021ASSIGNED TO EXAMINER
Wednesday, May 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 11, 2021NEW APPLICATION ENTERED IN TRAM